-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Madrigal Pharmaceuticals (NASDAQ:MDGL) Raised to Strong-Buy at B. Riley
B. Riley upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) from a hold rating to a strong-buy rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. B. Riley currently has $422.00 target price on the biopharmaceutical company’s stock, up from their prior target price of $236.00. Several other brokerages […]
B. Riley upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) from a hold rating to a strong-buy rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. B. Riley currently has $422.00 target price on the biopharmaceutical company’s stock, up from their prior target price of $236.00. Several other brokerages […]
